Ingredion (INGR) has opened Q1 2026 earnings season with a fresh look at its recent performance, coming off Q4 2025 revenue of US$1.8b, basic EPS of US$2.59 and trailing twelve month EPS of US$11.36. Over the past few quarters, the company has seen revenue move between US$1.8b and US$1.9b, while quarterly EPS ranged from US$2.59 to US$3.05. This has taken place against a backdrop of 1.9% revenue growth, 12.7% earnings growth and a net margin of 10.1% over the last year, which puts investor attention on how durable those margins appear from this point.

See our full analysis for Ingredion.

With the latest figures on the table, the next step is to see how these margins and growth trends line up with the prevailing narratives about Ingredion’s strengths, risks and long term earnings potential.

Margins Hold at Around 10% While Revenue Stays Flat

• Over the last 12 months, Ingredion generated about US$7.2b of revenue with net income of US$729 million, which works out to a 10.1% net margin compared with 8.7% a year earlier, even though reported revenue growth was only 1.9% versus 11.2% for the wider US market.
• Analysts' consensus view links this margin profile to the shift into higher value ingredients, and the data partly backs that up but also shows the trade off:
  • The 12.7% earnings growth on relatively flat revenue suggests higher margin products and cost efficiency are helping profit, while volume growth lags the 11.2% US market revenue pace mentioned in the analysis.
  • At the same time, the consensus narrative flags that legacy areas like industrial starches and high fructose corn syrup are under pressure, which matches the modest 1.9% revenue growth figure and highlights how much the current 10.1% margin depends on the specialty mix holding up.

To see how the community connects this margin story with Ingredion's longer term direction, check the full range of narratives and viewpoints in one place See what the community is saying about Ingredion.

EPS Around US$11.36 Versus Slower Top Line

• Trailing twelve month basic EPS sits at US$11.36 on US$7.2b of revenue, while quarterly EPS over 2025 moved between US$2.59 and US$3.05 as quarterly revenue stayed in a tight US$1.76b to US$1.83b band, pointing to earnings progress without much top line expansion.
• Supporters of the bullish narrative argue that specialty ingredients and R&D driven products can keep EPS growing, and the reported numbers both support and test that claim:
  • The 12.7% earnings growth over the last year fits with the idea that higher value products and cost efficiencies are helping profits, even as the revenue line inches forward at 1.9% a year.
  • However, the same narrative notes that some margin strength in areas like Texture & Healthful Solutions reflected one off sourcing and cost benefits, and the recent EPS range of US$2.59 to US$3.05 across 2025 quarters shows why investors may want to see how much of the US$11.36 EPS level can be repeated without those temporary supports.

Bulls point to these EPS trends as proof the business model is working, so if you want the full optimistic take built around them, it is worth reading the detailed bull case 🐂 Ingredion Bull Case.

Low 9.3x P/E Versus Peers and DCF Fair Value

• Ingredion trades on a trailing P/E of 9.3x at a share price of US$107.13, compared with 34.5x for peers and 19.6x for the US Food industry, and the stock is described as sitting about 49.8% below a DCF fair value of roughly US$213.57 while also offering a 3.06% dividend yield.
• Critics highlight that slower growth can justify a lower multiple, and the figures shed light on why the bearish angle focuses on the revenue line:
  • The 1.9% revenue growth rate and reference to forecast earnings growth of 3% per year are both below the broader US market figures mentioned, which helps explain why the P/E sits well under sector averages despite a 10.1% net margin.
  • At the same time, the combination of a low 9.3x P/E and the gap to the US$213.57 DCF fair value reference gives value focused investors a very different read than those who are more concerned about the slower top line and the reliance on specialty ingredients to carry future profit.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Ingredion on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If the mix of optimism and caution in this article leaves you undecided, take a closer look at the underlying data yourself and move quickly to shape your own view. You can start with the 4 key rewards.

See What Else Is Out There

Ingredion pairs a 10.1% net margin and US$11.36 EPS with only 1.9% revenue growth. This combination raises questions about how much further the current model can stretch.

If you are concerned that slow top line growth could limit upside, it may be useful to quickly check stocks screened as 51 high quality undervalued stocks before committing too much capital.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.